PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
30.46%
Growth of 30.46% while CRON.TO shows flat revenue. Bruce Berkowitz would examine growth quality advantage.
9.53%
Cost increase while CRON.TO reduces costs. John Neff would investigate competitive disadvantage.
41.93%
Gross profit growth below 50% of CRON.TO's 1172.95%. Michael Burry would check for structural issues.
8.79%
Margin change of 8.79% while CRON.TO shows flat margins. Bruce Berkowitz would examine quality advantage.
42.65%
R&D change of 42.65% while CRON.TO maintains spending. Bruce Berkowitz would investigate effectiveness.
17.56%
G&A growth less than half of CRON.TO's 103.38%. David Dodd would verify if efficiency advantage is structural.
-7.29%
Marketing expense reduction while CRON.TO shows 0.00% growth. Joel Greenblatt would examine competitive risk.
173.36%
Other expenses growth above 1.5x CRON.TO's 35.25%. Michael Burry would check for concerning trends.
8.78%
Operating expenses growth less than half of CRON.TO's 95.07%. David Dodd would verify sustainability.
8.99%
Total costs growth less than half of CRON.TO's 62.66%. David Dodd would verify sustainability.
129.01%
Interest expense growth while CRON.TO reduces costs. John Neff would investigate differences.
51.17%
D&A growth 1.25-1.5x CRON.TO's 35.25%. Martin Whitman would scrutinize asset base.
147.59%
EBITDA growth exceeding 1.5x CRON.TO's 69.42%. David Dodd would verify competitive advantages.
136.32%
Margin change of 136.32% while CRON.TO is flat. Bruce Berkowitz would examine quality.
82.60%
Similar operating income growth to CRON.TO's 85.71%. Walter Schloss would investigate industry trends.
86.66%
Margin change of 86.66% while CRON.TO is flat. Bruce Berkowitz would examine quality.
163.77%
Other expenses growth while CRON.TO reduces costs. John Neff would investigate differences.
100.85%
Pre-tax income growth 1.25-1.5x CRON.TO's 84.94%. Bruce Berkowitz would examine sustainability.
100.65%
Margin change of 100.65% while CRON.TO is flat. Bruce Berkowitz would examine quality.
-96.84%
Both companies reducing tax expense. Martin Whitman would check patterns.
100.85%
Net income growth 1.25-1.5x CRON.TO's 87.84%. Bruce Berkowitz would examine sustainability.
100.65%
Margin change of 100.65% while CRON.TO is flat. Bruce Berkowitz would examine quality.
101.37%
EPS growth 1.25-1.5x CRON.TO's 91.82%. Bruce Berkowitz would examine sustainability.
100.00%
Similar diluted EPS growth to CRON.TO's 91.82%. Walter Schloss would investigate industry trends.
20.86%
Share count reduction exceeding 1.5x CRON.TO's 48.41%. David Dodd would verify capital allocation.
61.58%
Diluted share reduction below 50% of CRON.TO's 48.41%. Michael Burry would check for concerns.